Skip to content

Risk Stratifying COPD Exacerbations

Risk Stratifying COPD Exacerbations: a Prospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05852327
Acronym
ProECOPD_23
Enrollment
500
Registered
2023-05-10
Start date
2023-02-01
Completion date
2025-02-01
Last updated
2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation

Brief summary

To identify clinical characteristics on presentation which predict differential outcomes in patients with exacerbation of COPD.

Detailed description

Exacerbations of COPD (ECOPD) are heterogenous but are often considered as a single clinical entity. Clinical characteristics on presentation may predict outcome of patients with ECOPD. DECAF score was previously proposed to predict in-hospital mortality but has not been validated in Asian subjects. ROME classification was recently proposed to better risk stratify ECOPD according to symptoms, physiological parameters and laboratory findings on admission, but no prospective validation study is available so far. This study aims to identify clinical characteristics on presentation to predict outcome of patients with ECOPD.

Interventions

OTHERObservation only

Observation only

Sponsors

Pamela Youde Nethersole Eastern Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years

Inclusion criteria

* Background history of COPD, defined by the GOLD 2023 guidelines * Presented with exacerbation of COPD, defined by the GOLD 2023 guidelines * Age \>= 18 years old * Informed consent available

Exclusion criteria

* Age \< 18 years old * No informed consent

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality3-monthNumber of patients died during hospitalization of ECOPD
3-month mortality3-monthNumber of patients died 3 months after ECOPD
Recurrent ECOPD3-monthNumber of patients with recurrent ECOPD post-discharge
Viral etiology3-monthFrequency of various viral etiology identified during ECOPD
Bacterial etiology3-monthFrequency of various bacterial etiology identified during ECOPD

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026